Arrowpoint Investment Partners (Singapore) Pte. Ltd.

Position in DXCM — Dexcom Inc

CIK 2032331 SINGAPORE, U0

Back to DXCM Full portfolio

Position in DXCM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$227,838

-$1,368,577 QoQ

Shares Held

3,628

-84.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Mar 31, 2025

CallValue

$1,843,830

CallShares

27,000

PutValue

$1,932,607

PutShares

28,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $3,562,745 across 2 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)	Open
1	BRKR	Bruker Corp	52,780	$3,176,300
2	AVR	Anteris Technologies Global Corp.	39,233	$386,445

All Filings in DXCM

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$227,838	3,628	-84.5%	Shares	Defined	2026-05-14
2025-03-31	$1,932,607	28,300	—	Put	Defined	2025-05-13
2025-03-31	$1,843,830	27,000	—	Call	Defined	2025-05-13
2025-03-31	$1,596,415	23,377	—	Shares	Defined	2025-05-13
No filing history on record for this holder in this stock.